Exhibitor

LYO-X AG uses PK/PD modelling to support the development of new targeted drugs at the cutting edge of science and technology. As a global leader in Modelling & Simulation and Quantitative Systems Pharmacology, LYO-X works with over 150 companies globally, ranging from biotech start-ups to large pharma, providing predictive solutions for robust and efficient drug development.

Integrated Biologix GmbH (iBX) provides fully integrated non-clinical development support for biopharmaceuticals at all stages of the drug-development cycle from target/candidate selection through IND/CTA and clinical development up to approval. iBX can help select the right candidate, design, interpret & communicate relevant non-clinical development programs, to achieve successful regulatory approvals.